Assignee
PSIOXUS THERAPEUTICS LTD
GB·15 granted patents·5 pending applications·30 citations·filing 2013–2021
Top patents by PatentIndex Score
20 records- 0191US10034905B2Group B adenovirus modified in the E4orf4 regionPSIOXUS THERAPEUTICS LTD·Filed 2015·Granted Jul 31, 2018·9 cites·26 claims
- 0290US10849945B2Oncolytic adenovirus encoding a B7 protein or active fragmentPSIOXUS THERAPEUTICS LTD·Filed 2018·Granted Dec 1, 2020·3 cites·23 claims
- 0388US11155622B2Virus encoding an anti-TCR-complex antibody or fragmentPSIOXUS THERAPEUTICS LTD·Filed 2016·Granted Oct 26, 2021·3 cites·20 claims
- 0487US10548929B2Oncolytic adenovirus encoding a therapeutic protein or active fragmentPSIOXUS THERAPEUTICS LTD·Filed 2017·Granted Feb 4, 2020·4 cites·13 claims
- 0584US9987314B2Oncolytic adenoviruses armed with heterologous genesPSIOXUS THERAPEUTICS LTD·Filed 2014·Granted Jun 5, 2018·6 cites·23 claims
- 0683US11000559B2Oncolytic adenovirus encoding a B7 proteinPSIOXUS THERAPEUTICS LTD·Filed 2016·Granted May 11, 2021·2 cites·21 claims
- 0781US11439678B2Oncolytic adenoviruses armed with heterologous genesPSIOXUS THERAPEUTICS LTD·Filed 2018·Granted Sep 13, 2022·1 cites·27 claims
- 0876US10124028B2Oncolytic adenovirus encoding a B7 protein or active fragmentPSIOXUS THERAPEUTICS LTD·Filed 2016·Granted Nov 13, 2018·1 cites·18 claims
- 0973US9115337B2Chimeric adenoviruses for use in cancer treatmentPSIOXUS THERAPEUTICS LTD·Filed 2013·Granted Aug 25, 2015·1 cites·4 claims
- 1073US2021338753A1Oncolytic adenovirus encoding a b7 proteinPSIOXUS THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1165US10322152B2Oncolytic adenovirus encoding a B7 proteinPSIOXUS THERAPEUTICS LTD·Filed 2017·Granted Jun 18, 2019·0 cites·9 claims
- 1264US9234185B2Chimeric adenoviruses for use in cancer treatmentPSIOXUS THERAPEUTICS LTD·Filed 2014·Granted Jan 12, 2016·0 cites·9 claims
- 1362US9034344B2Chimeric adenoviruses for use in cancer treatmentPSIOXUS THERAPEUTICS LTD·Filed 2013·Granted May 19, 2015·0 cites·5 claims
- 1459US11173186B2Dosing regime and formulations for type B adenovirusPSIOXUS THERAPEUTICS LTD·Filed 2014·Granted Nov 16, 2021·0 cites·19 claims
- 1554US11142580B2Oncolytic virus and methodPSIOXUS THERAPEUTICS LTD·Filed 2018·Granted Oct 12, 2021·0 cites·18 claims
- 1652US2017112923A1Multi-valent adjuvant displayPSIOXUS THERAPEUTICS LTD·Filed 2016·Application pending·0 cites
- 1744US10472648B2Method of making adenovirus and corresponding plasmidsPSIOXUS THERAPEUTICS LTD·Filed 2014·Granted Nov 12, 2019·0 cites·18 claims
- 1844US2022340885A1Method of purifying a composition comprising a group b adenovirusPSIOXUS THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 1937US2017073647A1Process for the preparation of group b adenovirusesPSIOXUS THERAPEUTICS LTD·Filed 2015·Application pending·0 cites
- 2037US2017313990A1A process for the production of adenovirusPSIOXUS THERAPEUTICS LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PSIOXUS THERAPEUTICS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →